Prognosis of severe drug-induced acute interstitial nephritis requiring renal replacement therapy.

Abstract

OBJECTIVE:

Drug-induced acute interstitial nephritis (DAIN) is often associated with improved outcomes, whereas some patients may still progress to chronic kidney disease (CKD). The aim of this study was to evaluate the prognosis of patients with severe DAIN requiring renal replacement therapy (RRT) at baseline, and to explore the risk factors of progression to CKD.

METHODS:

We performed a retrospective study of patients with severe DAIN confirmed by renal biopsies in our center over a 10 years period, all the patients received RRT at presentation. The clinical and pathological characteristics at baseline were recorded, and the outcomes (renal function recovered or progressed to CKD) during follow-ups were also evaluated. Univariate and multivariate logistic regression analysis were performed to identify the independent risk factors of progression to CKD.

RESULTS:

Seventy-two patients who met the inclusion criteria were enrolled, 13 patients (18.0%) progressed to CKD (GFR < 60 ml/min/1.73 m2) after at least 6 months of follow-up, the remaining 59 patients achieved a favorable renal function recovery. Compared with patients who achieved renal function recovery (recovery group), the patients progressed to CKD (progression group) were older and had longer interval from symptom onset to treatment with steroids. The peak serum cystatin C concentration was higher in progression group than recovery group. Higher score of interstitial fibrosis/tubular atrophy (IFTA) and more interstitial inflammatory cells infiltration were detected in renal tissue in progression group. According to multivariable analysis, higher peak cystatin C concentration (OR = 2.443, 95% CI 1.257, 4.746, p = 0.008), longer interval to treatment with corticosteroids (OR = 1.183, 95% CI 1.035, 1.352, p = 0.014) were independent risk factors of progression to CKD. The cutoff value of cystatin C concentration was 4.34 mg/L, at which the sensitivity and specificity were 76.9% and 89.3%, respectively; the cutoff value of interval to treatment with corticosteroids was 22.5 days, at which the sensitivity and specificity were 81.8% and 79.5%, respectively.

CONCLUSION:

Renal function was reversible in majority of patients with severe DAIN requiring RRT when early identification and treatment. Higher peak cystatin C concentration and longer interval to treatment with corticosteroids associated with worse renal prognosis.

• Authors: Li Huang, Shaoshan Liang, Jianhua Dong, Wenjing Fan, Caihong Zeng, Ti Zhang, Shuiqin Cheng, Yongchun Ge
• Journal: Renal failure (Ren Fail) Vol. 43 Issue 1 Pg. 1020-1027 (Dec 2021) ISSN: 1525-6049 [Electronic] England
• PMID: 34187299 (Publication Type: Journal Article)

Chemical References

• Cystatin C
• Glucocorticoids
• Creatinine

Topics

• Adult
• Biopsy
• Creatinine (blood)
• Cystatin C (blood)
• Disease Progression
• Female
• Glucocorticoids (administration & dosage)
• Humans
• Kidney (pathology)
• Logistic Models
• Male
• Middle Aged
• Multivariate Analysis
• Nephritis, Interstitial (chemically induced, pathology, therapy)
• Prognosis
• Recovery of Function
• Renal Insufficiency, Chronic (physiopathology)
• Renal Replacement Therapy
• Retrospective Studies
• Risk Factors